Optiver Holding
NVO

Optiver Holding’s Novo Nordisk NVO Stock Holding History

Optiver Holding’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204M Buy
4,245,200
+2,988,900
+238% +$128M 0.05% 114
2026
Q1 		$46.2M Sell
1,256,300
-1,552,000
-55% -$73.5M 0.02% 193
2025
Q4 		$143M Buy
2,808,300
+896,900
+47% +$45.9M 0.05% 92
2025
Q3 		$106M Buy
1,911,400
+1,168,300
+157% +$68.4M 0.04% 87
2025
Q2 		$51.3M Buy
743,100
+133,000
+22% +$9.05M 0.02% 106
2025
Q1 		$42.4M Buy
610,100
+80,200
+15% +$6.62M 0.02% 102
2024
Q4 		$45.6M Buy
529,900
+204,800
+63% +$22.1M 0.02% 106
2024
Q3 		$38.7M Sell
325,100
-199,000
-38% -$26.5M 0.02% 123
2024
Q2 		$74.8M Sell
524,100
-214,100
-29% -$28.4M 0.04% 101
2024
Q1 		$94.8M Buy
738,200
+603,000
+446% +$71.8M 0.05% 109
2023
Q4 		$14M Sell
135,200
-315,200
-70% -$31.2M 0.01% 258
2023
Q3 		$41M Sell
450,400
-124,000
-22% -$10.9M 0.03% 162
2023
Q2 		$46.5M Buy
574,400
+65,600
+13% +$5.36M 0.03% 158
2023
Q1 		$40.5M Buy
508,800
+336,200
+195% +$23.8M 0.03% 181
2022
Q4 		$11.7M Buy
172,600
+36,000
+26% +$2.11M 0.01% 230
2022
Q3 		$6.8M Sell
136,600
-48,600
-26% -$2.6M 0.01% 195
2022
Q2 		$10.3M Buy
+185,200
New +$10.3M 0.01% 159

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Optiver Holding's NVO Position: Q2 2026 in Review

Optiver Holding opened a new position in Novo Nordisk (NVO) in Q2 2026: 47,719 shares worth $2.29M. The stake represents ﹤0.01% of the portfolio and ranks #544 among its holdings. This is a return to the name: Optiver Holding previously reported a position in NVO as recently as Q4 2025.

Optiver Holding first reported a position in NVO in Q3 2021 and has held it in 15 quarters since. The position peaked at $50.1M in Q4 2025. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Optiver Holding held 47,719 shares of Novo Nordisk worth $2.29M as of Q2 2026.
  • Novo Nordisk was a new Optiver Holding position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #544 holding.
  • Optiver Holding first reported a position in Novo Nordisk in Q3 2021 and has held it in 15 quarters since.
  • Optiver Holding's Novo Nordisk position peaked at $50.1M in Q4 2025.
  • 1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.